NCT03652428 2026-03-02
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
University of Maryland, Baltimore
Phase 1/2 Recruiting
University of Maryland, Baltimore
Institute of Oncology Ljubljana
RenovoRx
University of Saskatchewan
Oslo University Hospital
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School